Literature DB >> 27230288

Secondary negative symptoms - A review of mechanisms, assessment and treatment.

Matthias Kirschner1, André Aleman2, Stefan Kaiser3.   

Abstract

Negative symptoms in schizophrenia may be classified as primary or secondary. Primary negative symptoms are thought to be intrinsic to schizophrenia, while secondary negative symptoms are caused by positive symptoms, depression, medication side-effects, social deprivation or substance abuse. Most of the research on secondary negative symptoms has aimed at ruling them out in order to isolate primary negative symptoms. However, secondary negative symptoms are common and can have a major impact on patient-relevant outcomes. Therefore, the assessment and treatment of secondary negative symptoms are clinically relevant. Furthermore, understanding the mechanisms underlying secondary negative symptoms can contribute to an integrated model of negative symptoms. In this review we provide an overview of concepts, evidence, assessment and treatment for the major causes of secondary negative symptoms. We also summarize neuroimaging research relevant to secondary negative symptoms. We emphasize the relevance of recent developments in psychopathological assessment of negative symptoms, such as the distinction between amotivation and diminished expression, which have only rarely been applied in research on secondary negative symptoms.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antipsychotic medication; Depression; Negative symptoms; Psychosis; Schizophrenia; Social deprivation

Mesh:

Substances:

Year:  2016        PMID: 27230288     DOI: 10.1016/j.schres.2016.05.003

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  39 in total

1.  The Effect of Substance Use on 10-Year Outcome in First-Episode Psychosis.

Authors:  Melissa A Weibell; Wenche Ten Velden Hegelstad; Bjørn Auestad; Jørgen Bramness; Julie Evensen; Ulrik Haahr; Inge Joa; Jan Olav Johannessen; Tor Ketil Larsen; Ingrid Melle; Stein Opjordsmoen; Bjørn Rishovd Rund; Erik Simonsen; Per Vaglum; Thomas McGlashan; Patrick McGorry; Svein Friis
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 2.  Inefficient neural system stabilization: a theory of spontaneous resolutions and recurrent relapses in psychosis

Authors:  Lena Palaniyappan
Journal:  J Psychiatry Neurosci       Date:  2019-11-01       Impact factor: 6.186

3.  Physio-somatic symptoms in schizophrenia: association with depression, anxiety, neurocognitive deficits and the tryptophan catabolite pathway.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Supaksorn Thika; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; George Anderson; Cristiano Noto; Rada Ivanova; Michael Maes
Journal:  Metab Brain Dis       Date:  2017-03-03       Impact factor: 3.584

4.  In Schizophrenia, Depression, Anxiety, and Physiosomatic Symptoms Are Strongly Related to Psychotic Symptoms and Excitation, Impairments in Episodic Memory, and Increased Production of Neurotoxic Tryptophan Catabolites: a Multivariate and Machine Learning Study.

Authors:  Buranee Kanchanatawan; Supaksorn Thika; Sunee Sirivichayakul; André F Carvalho; Michel Geffard; Michael Maes
Journal:  Neurotox Res       Date:  2018-01-29       Impact factor: 3.911

5.  Cognitive Impairment and Diminished Neural Responses Constitute a Biomarker Signature of Negative Symptoms in Psychosis.

Authors:  Matthew E Hudgens-Haney; Brett A Clementz; Elena I Ivleva; Matcheri S Keshavan; Godfrey D Pearlson; Elliot S Gershon; Sarah K Keedy; John A Sweeney; Florence Gaudoux; Pierre Bunouf; Benoit Canolle; Françoise Tonner; Silvia Gatti-McArthur; Carol A Tamminga
Journal:  Schizophr Bull       Date:  2020-02-11       Impact factor: 9.306

6.  Factor Structure, Convergent, and Divergent Validity of the Prodromal Questionnaire-Negative Symptom Subscale.

Authors:  Katherine M Pierce; Seth D Maxwell; Thomas M Olino; Shanna Cooper; Lauren M Ellman
Journal:  Assessment       Date:  2020-01-19

Review 7.  A Transdiagnostic Review of Negative Symptom Phenomenology and Etiology.

Authors:  Gregory P Strauss; Alex S Cohen
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

Review 8.  Schizophrenia: synthetic strategies and recent advances in drug design.

Authors:  Maria Azmanova; Anaïs Pitto-Barry; Nicolas P E Barry
Journal:  Medchemcomm       Date:  2018-03-16       Impact factor: 3.597

9.  Antipsychotic drugs: challenges and future directions.

Authors:  Oliver H Howes; Stephen J Kaar
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

10.  Correspondence between negative symptoms and potential sources of secondary negative symptoms over time.

Authors:  Aida Farreny; Mark Savill; Stefan Priebe
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-06-02       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.